Compensated reduction in Leydig cell function is associated with lower semen quality variables: A study of 8182 European young men

Human Reproduction

Volumn 31, Issue 5, 2016, Pages 947-957

  Jorgensen N ^a   Joensen, U N ^a   Toppari, J ^b   Punab, M ^c   Erenpreiss, J ^d   Zilaitiene, B ^e   Paasch, U ^f   Salzbrunn, A ^g   Fernandez, M F ^h,i   Virtanen, H E ^b   Matulevicius, V ^e   Olea, N ^h,i   Jensen, T K ^a   Petersen, J H ^a,j   Skakkebaek N E ^a   Andersson, A M ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF TURKU   (Finland)

^c TARTU UNIVERSITY HOSPITAL   (Estonia)

^d LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTRE   (Latvia)

^e LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^f UNIVERSITY OF LEIPZIG   (Germany)

^g UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^h UNIVERSITY OF GRANADA   (Spain)

ⁱ CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^j UNIVERSITY OF COPENHAGEN   (Denmark)

more..

Author keywords

Leydig cell failure function; luteinising hormone; semen quality; testosterone; young men

Indexed keywords

LUTEINIZING HORMONE; TESTOSTERONE;

ADULT; ANDROGEN DEFICIENCY; ARTICLE; BLOOD SAMPLING; CELL FUNCTION; CROSS-SECTIONAL STUDY; DENMARK; ESTONIA; FINLAND; GERMANY; HUMAN; LATVIA; LEYDIG CELL; LITHUANIA; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MALE FERTILITY; SEMEN ANALYSIS; SPAIN; SPERM QUALITY; SPERMATOZOON; SPERMATOZOON COUNT; SPERMATOZOON DENSITY; SPERMATOZOON MOTILITY; TESTOSTERONE BLOOD LEVEL; WORLD HEALTH ORGANIZATION; BLOOD; EUROPE; FERTILITY; PHYSIOLOGY; PROSPECTIVE STUDY; REFERENCE VALUE;

ADULT; CROSS-SECTIONAL STUDIES; EUROPE; FERTILITY; HUMANS; LEYDIG CELLS; LUTEINIZING HORMONE; MALE; PROSPECTIVE STUDIES; REFERENCE VALUES; SEMEN ANALYSIS; TESTOSTERONE;

EID: 84966480831     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dew021     Document Type: Article

References (38)

1. Andersen AG, Jensen TK, Carlsen E, Jorgensen N, Andersson AM, Krarup T, Keiding N, Skakkebaek NE. High frequency of sub-optimal semen quality in an unselected population of young men. Hum Reprod 2000;15:366-372.
2. Andersson AM, Jorgensen N, Frydelund-Larsen L, Rajpert-De Meyts E, Skakkebaek NE. Impaired Leydig cell function in infertile men: A study of 357 idiopathic infertile men and 318 proven fertile controls. J Clin Endocrinol Metab 2004;89:3161-3167.
3. Andersson AM, Jensen TK, Juul A, Petersen JH, Jorgensen T, Skakkebaek NE. Secular decline in male testosterone and sex hormone binding globulin serum levels in Danish population surveys. J Clin Endocrinol Metab 2007; 92:4696-4705.
4. Auharek SA, de Franca LR, McKinnell C, Jobling MS, Scott HM, Sharpe RM. Prenatal plus postnatal exposure to Di(n-Butyl) phthalate and/or flutamide markedly reduces final sertoli cell number in the rat. Endocrinology 2010;151:2868-2875.
5. Axelsson J, Rylander L, Rignell-Hydbom A, Giwercman A. No secular trend over the last decade in sperm counts among Swedish men from the general population. Hum Reprod 2011;26:1012-1016.
6. Bjornerem A, Straume B, Oian P, Berntsen GK. Seasonal variation of estradiol, follicle stimulating hormone, and dehydroepiandrosterone sulfate in women and men. J Clin Endocrinol Metab 2006;91:3798-3802.
7. Bonde JP, Ernst E, Jensen TK, Hjollund NH, Kolstad H, Henriksen TB, Scheike T, Giwercman A, Olsen J, Skakkebaek NE. Relation between semen quality and fertility: a population-based study of 430 first-pregnancy planners. Lancet 1998;352:1172-1177.
8. Camacho EM, Huhtaniemi IT, O'Neill TW, Finn JD, Pye SR, Lee DM, Tajar A, Bartfai G, Boonen S, Casanueva FF et al. Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. Eur J Endocrinol 2013;168:445-455.
9. Carlsen E, Swan SH, Petersen JH, Skakkebaek NE. Longitudinal changes in semen parameters in young Danish men from the Copenhagen area. Hum Reprod 2005;20:942-949.
10. Deslypere JP, Vermeulen A. Leydig cell function in normal men: effect of age, life-style, residence, diet, and activity. J Clin Endocrinol Metab 1984;59:955-962.
11. Drafta D, Schindler AE, Stroe E, Neacsu E. Age-related changes of plasma steroids in normal adult males. J Steroid Biochem 1982;17:683-687.
12. Fernandez MF, Duran I, Olea N, Avivar C, Vierula M, Toppari J, Skakkebaek NE, Jorgensen N. Semen quality and reproductive hormone levels in men from Southern Spain. Int J Androl 2012;35:1-10.
13. Gray A, Feldman HA, McKinlay JB, Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 1991;73:1016-1025.
14. Guzick DS, Overstreet JW, Factor-Litvak P, Brazil CK, Nakajima ST, Coutifaris C, Carson SA, Cisneros P, Steinkampf MP, Hill JA et al. Sperm morphology, motility, and concentration in fertile and infertile men. N Engl J Med 2001;345:1388-1393.
15. Hyde Z, Norman PE, Flicker L, Hankey GJ, Almeida OP, McCaul KA, Chubb SA, Yeap BB. Low free testosterone predicts mortality from cardiovascular disease but not other causes: the Health in Men Study. J Clin Endocrinol Metab 2012;97:179-189.
16. Jedrzejczak P, Taszarek-Hauke G, Hauke J, Pawelczyk L, Duleba AJ. Prediction of spontaneous conception based on semen parameters. Int J Androl 2008;31:499-507.
17. Jensen TK, Jacobsen R, Christensen K, Nielsen NC, Bostofte E. Good semen quality and life expectancy: a cohort study of 43,277 men. Am J Epidemiol 2009;170:559-565.
18. Jorgensen N, Auger J, Giwercman A, Irvine DS, Jensen TK, Jouannet P, Keiding N, Lebon C, MacDonald E, Pekuri AM et al. Semen analysis performed by different laboratory teams: an intervariation study. Int J Androl 1997;20:201-208.
19. Jorgensen N, Andersen AG, Eustache F, Irvine DS, Suominen J, Petersen JH, Andersen AN, Auger J, Cawood EHH, Horte A et al. Regional differences in semen quality in Europe. Hum Reprod 2001;16:1012-1019.
20. Jorgensen N, Carlsen E, Nermoen I, Punab M, Suominen J, Andersen AG, Andersson AM, Haugen TB, Horte A, Jensen TK et al. East-West gradient in semen quality in the Nordic-Baltic area: a study of men from the general population in Denmark, Norway, Estonia and Finland. Hum Reprod 2002;17:2199-2208.
21. Jorgensen N, Vierula M, Jacobsen R, Pukkala E, Perheentupa A, Virtanen HE, Skakkebk NE, Toppari J. Recent adverse trends in semen quality and testis cancer incidence among Finnish men. Int J Androl 2011;34:E37-E48.
22. Jorgensen N, Joensen UN, Jensen TK, Jensen MB, Almstrup K, Olesen IA, Juul A, Andersson AM, Carlsen E, Petersen JH et al. Human semen quality in the new millennium: a prospective cross-sectional population-based study of 4867 men. BMJ Open 2012;2:e000990.
23. Kilcoyne KR, Smith LB, Atanassova N, Macpherson S, McKinnell C, van den DS, Jobling MS, Chambers TJ, De GK, Verhoeven G et al. Fetal programming of adult Leydig cell function by androgenic effects on stem/progenitor cells. Proc Natl Acad Sci USA 2014;111:E1924-E1932.
24. Menkveld R, Stander FS, Kotze TJ, Kruger TF, van Zyl JA. The evaluation of morphological characteristics of human spermatozoa according to stricter criteria. Hum Reprod 1990;5:586-592.
25. Paasch U, Salzbrunn A, Glander HJ, Plambeck K, Salzbrunn H, Grunewald S, Stucke J, Skakkebaek NE, Jorgensen N. Semen quality in sub-fertile range for a significant proportion of young men from the general German population: a co-ordinated, controlled study of 791 men from Hamburg and Leipzig. Int J Androl 2008;31:93-102.
26. Plant TM, Marshall GR. The functional significance of FSH in spermatogenesis and the control of its secretion in male primates. Endocr Rev 2001;22:764-786.
27. Punab M, Zilaitiene B, Jorgensen N, Horte A, Matulevicius V, Peetsalu A, Skakkebaek NE. Regional differences in semen qualities in the Baltic region. Int J Androl 2002;25:243-252.
28. Skakkebaek NE, Rajpert-De ME, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 2001;16:972-978.
29. Slama R, Eustache F, Ducot B, Jensen TK, Jorgensen N, Horte A, Irvine S, Suominen J, Andersen AG, Auger J et al. Time to pregnancy and semen parameters: a cross-sectional study among fertile couples from four European cities. Hum Reprod 2002;17:503-515.
30. Stokes-Riner A, Thurston SW, Brazil C, Guzick D, Liu F, Overstreet JW, Wang C, Sparks A, Redmon JB, Swan SH. One semen sample or 2? Insights from a study of fertile men. J Androl 2007;28:638-643.
31. Tajar A, Forti G, O'Neill TW, Lee DM, Silman AJ, Finn JD, Bartfai G, Boonen S, Casanueva FF, Giwercman A et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab 2010;95:1810-1818.
32. Tajar A, Huhtaniemi IT, O'Neill TW, Finn JD, Pye SR, Lee DM, Bartfai G, Boonen S, Casanueva FF, Forti G et al. Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS). J Clin Endocrinol Metab 2012;97:1508-1516.
33. van den Driesche S, Kolovos P, Platts S, Drake AJ, Sharpe RM. Inter-relationship between testicular dysgenesis and Leydig cell function in the masculinization programming window in the rat. PLoS One 2012;7:e30111.
34. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-3672.
35. Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morales A et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J Androl 2009;30:1-9.
36. World Health Organization. (1992) WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. Cambridge, UK: Cambridge Univeristy Press.
37. World Health Organization. (2010) WHO laboratory manual for the examination and processing of human semen. Geneva, Switzerland: WHO Press.
38. Yeap BB, Alfonso H, Chubb SA, Handelsman DJ, Hankey GJ, Almeida OP, Golledge J, Norman PE, Flicker L. In older men an optimal plasma testosterone is associated with reduced all-cause mortality and higher dihydrotestosterone with reduced ischemic heart disease mortality, while estradiol levels do not predict mortality. J Clin Endocrinol Metab 2014;99:E9-E18.